Literature DB >> 25388392

High yield recovery of equine mesenchymal stem cells from umbilical cord matrix/Wharton's jelly using a semi-automated process.

Timo Z Nazari-Shafti1, Ivone G Bruno, Rudy F Martinez, Michael E Coleman, Eckhard U Alt, Scott R McClure.   

Abstract

Umbilical cord is an abundant source of perinatal, plastic adherent mesenchymal stem cells (UC-MSCs). UC-MSCs exhibit robust stemness and strong immunosuppressive and regenerative effects in vivo. This protocol describes enzymatic and mechanical dissociation of umbilical cord matrix (Wharton's jelly) that results in efficient isolation of large numbers of fresh nucleated umbilical cord regenerative cells (UC-RCs) that, when cultured on plastic, exhibit similar characteristics of UC-MSCs. This protocol potentially alleviates the need for culture expansion to obtain large numbers of cells required for clinical application. Dissociation is achieved with a blend of collagenase and neutral proteases with agitation at 37 °C in a semi-automatic system. Average expected yield is 1.65 × 10(6) cells/g tissue with 93 % viability. This protocol has been successfully used to isolate an uncultured nucleated regenerative cell population (also referred to as stromal vascular fraction or SVF) from surgically debrided skin and from human, equine, and canine adipose tissue. The procedure requires less than 30 min for tissue dissection and less than 100 min for cell extraction. Quickly obtaining a large number of UC-RCs that have pluripotent differentiation capacity without the complexity and risks of culture expansion could simplify and expand the use of UC-RCs in clinical as well as research applications.

Entities:  

Mesh:

Year:  2015        PMID: 25388392     DOI: 10.1007/978-1-4939-1785-3_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity.

Authors:  Reka Agnes Haraszti; Rachael Miller; Matteo Stoppato; Yves Y Sere; Andrew Coles; Marie-Cecile Didiot; Rachel Wollacott; Ellen Sapp; Michelle L Dubuke; Xuni Li; Scott A Shaffer; Marian DiFiglia; Yang Wang; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther       Date:  2018-09-22       Impact factor: 11.454

Review 2.  Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.

Authors:  Mohamad Al Naem; Lynda Bourebaba; Katarzyna Kucharczyk; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

3.  Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells.

Authors:  Jennifer Rutering; Matthias Ilmer; Alejandro Recio; Michael Coleman; Jody Vykoukal; Eckhard Alt
Journal:  J Stem Cell Res Ther       Date:  2015

4.  Reproducible Derivation and Expansion of Corneal Mesenchymal Stromal Cells for Therapeutic Applications.

Authors:  Sayena Jabbehdari; Ghasem Yazdanpanah; Levi N Kanu; Khandaker N Anwar; Xiang Shen; Behnam Rabiee; Ilham Putra; Medi Eslani; Mark I Rosenblatt; Peiman Hematti; Ali R Djalilian
Journal:  Transl Vis Sci Technol       Date:  2020-02-21       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.